Operation of a facility for the study of infectious agents, vaccines and antivirals in adult and pediatric human subjects

Ended Indefinite Delivery Contract Awarded Last action

Contract number
75N93019D00031
Awardee
Awarding agency
Task orders
13 $42,112,378 obligated

Award facts

Combined order value
$42,112,378 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 58% used
$73,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost No Fee

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Operation of a facility for the study of infectious agents, vaccines and antivirals in adult and pediatric human… 75N93024F00001 National Institute of Allergy and Infectious Diseases (NIH) $7,783,176
A phase II, randomized, double-blind, placebo controlled trial to evaluate the antiviral activity, safety, and… 75N93023F00004 National Institute of Allergy and Infectious Diseases (NIH) $4,617,504
Phase i study of the infectivity, safety and immunogenicity of a recombinant, live-attenuated, bovine/human… 75N93023F00003 National Institute of Allergy and Infectious Diseases (NIH) $100,615
Phase i study of the infectivity, safety and immunogenicity of two recombinant, live-attenuated, bovine/human… 75N93023F00002 National Institute of Allergy and Infectious Diseases (NIH) $3,628,715
Operation of a facility for the study of infectious agents, vaccines and antivirals. 75N93023F00001 National Institute of Allergy and Infectious Diseases (NIH) $1,033,824
Long-term follow up of subjects previously enrolled in a phase i, randomized, double-blind, placebo-controlled study of… 75N93021F00001 National Institute of Allergy and Infectious Diseases (NIH) $74,789
The contractor shall perform a phase i clinical study to evaluate infectivity, safety, and immunogenicity of a single… 75N93020F00001 National Institute of Allergy and Infectious Diseases (NIH) $4,109,347
This task order is for the evaluation of safety and immunogenicity of live-attenuated pediatric RSV vaccine candidate… 75N93020F00002 National Institute of Allergy and Infectious Diseases (NIH) $79,824
Task order 75N93019F00134 (#004) under contract # 75N93019D00031 is in the amount of $249,990. The purpose of this task… National Institute of Allergy and Infectious Diseases (NIH) $209,627
Task order 75N93019F00135 (#005) under contract # 75N93019D00031 is in the amount of $1,746,830. The purpose of this… National Institute of Allergy and Infectious Diseases (NIH) $1,746,262
75N93019D00031; johns hopkins university; FY19; to #003 gates; POP 9/9/19-8/31/20; exploration of prime-boost… 75N93019F00133 National Institute of Allergy and Infectious Diseases (NIH) $130,471
75N93019D00031; johns hopkins university; FY19; to #001 RSV; POP 9/5/19-6/30/21; evaluation of live attenuated… 75N93019F00132 National Institute of Allergy and Infectious Diseases (NIH) $12,827,312
75N93019D00031; johns hopkins university; FY19; to #002; POP 9/5/19-5/4/21 75N93019F00131 National Institute of Allergy and Infectious Diseases (NIH) $5,770,911
Show all 13

Transactions

Action Obligated Date
Other Administrative Action P00005 $0
Change Order P00004 $0
Change Order P00003 $0
Change Order P00002 · Operations of a facility for the study of infectious agents, vaccines and antivirals in adult and pediatric human subjects for niaid $0
Other Administrative Action P00001 $0
Original award $0

Subawards

Subcontractor Amount Awarded
University Of Rochester OPERATION OF A FACILITY FOR THE STUDY OF INFECTIOUS AGENTS, VACCINES AND ANTIVIRALS IN ADULT AND PEDIATRIC HUMAN SUBJECTS The scope of this SOW is to perform… $788,289
Vanderbilt University Medical Center OPERATION OF A FACILITY FOR THE STUDY OF INFECTIOUS AGENTS, VACCINES AND ANTIVIRALS IN ADULT AND PEDIATRIC HUMAN SUBJECTS to perform a Phase I clinical study to… $934,118
University Of Vermont & State Agricultural College THIS TASK ORDER IS FOR THE EVALUATION OF SAFETY AND IMMUNOGENICITY OF LIVE-ATTENUATED PEDIATRIC RSV VACCINE CANDIDATE DNS/D1313/I1334L, DELIVERED AS NASAL… $684,182
Vanderbilt University Medical Center THIS TASK ORDER IS FOR THE EVALUATION OF SAFETY AND IMMUNOGENICITY OF LIVE-ATTENUATED PEDIATRIC RSV VACCINE CANDIDATE DNS/D1313/I1334L, DELIVERED AS NASAL… $801,614
University Of Rochester EVALUATION OF SAFETY AND IMMUNOGENICITY OF LIVE-ATTENUATED PEDIATRIC RSV VACCINE CANDIDATE. The Contractor shall perform a Phase I clinical study to evaluate… $846,366
Baylor College Of Medicine EVALUATION OF SAFETY AND IMMUNOGENICITY OF LIVE-ATTENUATED PEDIATRIC RSV VACCINE CANDIDATE. Design and conduct clinical trials $822,909

Quick answers

Who was awarded contract 75N93019D00031?

75N93019D00031 was awarded to The Johns Hopkins University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 5, 2019.

How much is contract 75N93019D00031 worth?

Orders under 75N93019D00031 have obligated $42,112,378. 75N93019D00031's own ceiling is $73,000,000.

How many orders have been placed under contract 75N93019D00031?

13 orders have been placed under 75N93019D00031, the latest on October 25, 2023.

Who can order from contract 75N93019D00031?

75N93019D00031 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N93019D00031 competed?

The extent of competition for 75N93019D00031 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login